News tagged with metastases
Bayer flags strong results of prostate cancer drug
German chemical and pharmaceutical group Bayer said Monday that its Alpharadin treatment for prostate cancer has shown positive results in advanced trials.
Jun 06, 2011 |
not rated yet |
0
Interventional radiologists provide hope in delaying growth, spread of breast cancer
The growth and spread of breast cancer tumors may be delayed with a promising treatment that combines two innovative strategies: blocking the enzyme needed to "energize" cancer cells and infusing a potent drug directly into ...
Mar 29, 2011 |
not rated yet |
0
Lymph node dissection is not essential in small screen-detected lung cancers, new research shows
Lymph node dissection, the current standard surgical treatment for localized non-small cell lung cancers, may be unnecessary in certain screen-detected early stage cases , according to a study published in the March issue ...
Mar 01, 2011 |
not rated yet |
0
Bone drug zoledronic acid may help prevent spread of early lung cancer
A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers ...
Feb 25, 2011 |
5 / 5 (1) |
0
Enzyme helps prepare lung tissue for metastatic development
A Massachusetts General Hospital (MGH) study has identified a new role for an important enzyme in preparing lung tissue for the development of metastases. Published in the early edition of Proceedings of the National Ac ...
Medicine & Health / Medical research
Feb 16, 2011 |
5 / 5 (1) |
0
|
Limited lymph node removal for certain breast cancer does not appear to result in poorer survival
Among patients with early-stage breast cancer that had spread to a nearby lymph node and who received treatment that included lumpectomy and radiation therapy, women who just had the sentinel lymph node removed (the first ...
Feb 08, 2011 |
not rated yet |
0
New drug for use in bone scans approved
The FDA has approved a New Drug Application (NDA) from the National Cancer Institute (NCI), part of the National Institutes of Health, for a new strength of a previously approved drug, Sodium Fluoride F18, for use in bone ...
Feb 01, 2011 |
not rated yet |
0
Novel immune system-based gene therapy induces strong responses in metastatic melanoma, sarcoma
Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing ...
Jan 31, 2011 |
5 / 5 (2) |
1
New approaches refine molecular imaging for detecting cancer metastasis
(PhysOrg.com) -- Researchers may be a step closer to improving the detection of metastatic tumors in an organism - in real time - using a non-invasive approach that pairs an imaging agent with a genetic element that only ...
Dec 16, 2010 |
not rated yet |
0
|
Defective cell surface 'glue' is key to tumor invasion
A remarkable discovery into how tumour cells invade normal tissue should lead to vital diagnostic tools and help develop strategies to stop the spread of cancer cells. A new study by scientists at the Montreal Neurological ...
Dec 13, 2010 |
not rated yet |
0
Denosumab delayed time to first skeletal-related side effect
For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San ...
Dec 10, 2010 |
not rated yet |
0
Researchers uncover new risk factors for brain metastases in breast cancer patients
Nearly one-fifth of all metastatic breast cancer patients develop brain metastases and have significantly shorter overall survival than patients who do not have brain involvement. One way to improve the affected patients' ...
Dec 09, 2010 |
not rated yet |
0
Expandable nanoparticles show promise in treating lethal abdominal cavity tumors
(PhysOrg.com) -- Too often, patients with ovarian cancer or mesothelioma develop metastases that spread within the abdominal cavity, and when that occurs, the chances of surviving beyond five years drops to less than 40%, ...
Nanotechnology / Bio & Medicine
Nov 25, 2010 |
5 / 5 (1) |
0
|
Study uses the patient's tumor to form vaccine
A new process for creating a personalized vaccine may become a crucial tool in helping patients with colorectal cancer develop an immune response against their own tumors. This dendritic cell (DC) vaccine, developed at Dartmouth ...
Nov 24, 2010 |
5 / 5 (1) |
0
Less invasive method for determining stage of lung cancer shows benefits
A comparison of two strategies to determine the stage of suspected non-small cell lung cancer (NSCLC) finds that the less invasive method is more effective at identifying a type of lung cancer that has spread, and may result ...
Nov 23, 2010 |
4 / 5 (1) |
0
Metastasis
Metastasis, or metastatic disease (sometimes abbreviated mets), is the spread of a disease from one organ or part to another non-adjacent organ or part. It was previously thought that only malignant tumor cells and infections have the capacity to metastasize; however, this is being reconsidered due to new research. The word metastasis means "displacement" in Greek, from μετά, meta, "next", and στάσις, stasis, "placement". The plural is metastases.
Cancer occurs after a single cell in a tissue is progressively genetically damaged to produce a cancer stem cell possessing a malignant phenotype. These cancer stem cells are able to undergo uncontrolled abnormal mitosis, which serves to increase the total number of cancer cells at that location. When the area of cancer cells at the originating site becomes clinically detectable, it is called primary tumor. Some cancer cells also acquire the ability to penetrate and infiltrate surrounding normal tissues in the local area, forming a new tumor. The newly formed "daughter" tumor in the adjacent site within the tissue is called a local metastasis.
Some cancer cells acquire the ability to penetrate the walls of lymphatic and/or blood vessels, after which they are able to circulate through the bloodstream (circulating tumor cells) to other sites and tissues in the body. This process is known (respectively) as lymphatic or hematogeneous spread.
After the tumor cells come to rest at another site, they re-penetrate through the vessel or walls, continue to multiply, and eventually another clinically detectable tumor is formed. This new tumor is known as a metastatic (or secondary) tumor. Metastasis is one of three hallmarks of malignancy (contrast benign tumors). Most tumors and other neoplasms can metastasize, although in varying degrees (e.g. basal cell carcinoma rarely metastasize).
When tumor cells metastasize, the new tumor is called a secondary or metastatic tumor, and its cells are like those in the original tumor. This means, for example, that, if breast cancer metastasizes to the lungs, the secondary tumor is made up of abnormal breast cells, not of abnormal lung cells. The tumor in the lung is then called metastatic breast cancer, not lung cancer.
For more information about Metastasis, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.